Thrombocytopenia: all 703 studies
Page 1 of 8. Open to participants first (151), then studies with results posted, then the rest; newest registration first within each.
- Time-limited Treatment With Avatrombopag Pre- and Post-CAR T-cell Therapy to Prevent Post-CAR T-cell CytopeniasNot yet recruitingNCT07895017Phase 2
- Neonatal Thrombocytopenia in the NICUNot yet recruitingNCT07882342
- Efficacy and Safety of Romiplostim N01 for Injection in Promoting Platelet Reconstitution After Allogeneic Hematopoietic Stem Cell TransplantationNot yet recruitingNCT07829952Phase 2
- Selective Mediterranean Diet in Immune ThrombocytopeniaNot yet recruitingNCT07798050Not applicable
- Thrombocytopenia Trajectories in Antiphospholipid Syndrome: A Multicenter Cohort StudyRecruitingNCT07757789Not applicable
- A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHANot yet recruitingNCT07738822Phase 1/2
- Efficacy and Safety of MegaLT Injection for Platelet Recovery After Umbilical Cord Blood TransplantationNot yet recruitingNCT07696767Early Phase 1
- EFFECT OF PLATELET CONCENTRATE TRANSFUSION ON MICROCIRCULATORY ENDOTHELIAL FUNCTION IN INTENSIVE CARE UNITNot yet recruitingNCT07682246
- Role of Viscoelastometric Testing in the Development and Validation of a Clinical-biological Score for Predicting Bleeding in Patients With Malignant Haematological Disorders and Severe ThrombocytopeniaRecruitingNCT07653672
- A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced ThrombocytopeniaeNot yet recruitingNCT07647029Phase 2
- Prediction of Platelet Function Using Viscoelastic Test (ROTEM® Sigma) in Obstetric Anesthesia.RecruitingNCT07616349
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsRecruitingNCT07586826Phase 2
- Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid TumorsRecruitingNCT07586813Phase 2
- Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With CytopeniasNot yet recruitingNCT07447817Phase 2
- Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCTRecruitingNCT07442513Phase 3
- Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)RecruitingNCT07441720Phase 2
- Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.RecruitingNCT07278661Phase 2
- Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand DiseaseRecruitingNCT07273721Phase 2
- Herombopag Treated T-DM1 Induced Platelet ReductionRecruitingNCT07257809Phase 2
- A Multicenter, Open-label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Romiplostim N01 in the Treatment of Thrombocytopenia Associated With Concurrent/Sequential Chemoradiotherapy and Chemotherapy Combined With/Without Immunotherapy in Solid TumorsNot yet recruitingNCT07185893Not applicable
- Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot StudyRecruitingNCT07133659Phase 4
- Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT)RecruitingNCT07110090Phase 1
- Hematological Disorders in EHPVO PatientsNot yet recruitingNCT07108023
- The Holistic StudyNot yet recruitingNCT07051915Phase 3
- A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPYNot yet recruitingNCT07019545Phase 2
- A Dose-escalation Study Followed by a Dose Optimal Study to Evaluate the Safety and Efficacy of CID-103 in Adults With Chronic Immune ThrombocytopeniaRecruitingNCT07017725Phase 1/2
- "Cytotoxic T Lymphocyte-Associated Antigen-4 (CTLA-4) Gene Single-nucleotide Polymorphism in Primary Immune Thrombocytopenic Purpura in Children"Not yet recruitingNCT07014904
- Risk Factors for Hospitalization and Transfusion Criteria in Patients With Dengue Virus InfectionRecruitingNCT07007585
- Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional TrialRecruitingNCT06992128Phase 2
- Research for Plasma Biomarkers Associated With Fatigue in Thrombocytopenic PatientsRecruitingNCT06979765Not applicable
- RESTI Registry: Spanish Registry of Primary Immune Thrombocytopenia and Other Immune ThrombocytopeniaRecruitingNCT06919341
- The Study of Different Cycles of High-dose Dexamethasone in the Treatment of ITPNot yet recruitingNCT06913374Phase 2/3
- A Study of TQB3473 Tablets Compared to Placebo in the Treatment of Adult Primary Immune ThrombocytopeniaRecruitingNCT06900920Phase 3
- Apixaban in ThrombocytopeniaRecruitingNCT06886516Early Phase 1
- Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung DiseaseRecruitingNCT06869499Not applicable
- A Phase 1/2 Study of ESG206 in Patients With Primary Immune ThrombocytopeniaRecruitingNCT06853444Phase 1/2
- Clinical Efficacy of Platelet TransfusionRecruitingNCT06805097
- An Open, Exploratory Clinical Study of CM336 in the Treatment of Immune ThrombocytopeniaRecruitingNCT06799611Phase 2
- Ripertamab Plus Eltrombopag vs. Eltrombopag in ITP Patients Post-Steroid FailureNot yet recruitingNCT06790888Not applicable
- Luspatercept for Clonal Cytopenias of Uncertain SignificanceRecruitingNCT06788691Phase 2
- BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune DiseasesRecruitingNCT06787989Phase 1
- Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical CancerNot yet recruitingNCT06745219Phase 2
- Longitudinal Cohort of Thrombosis and Hemostasis DiseasesRecruitingNCT06727669
- Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related ThrombocytopeniaRecruitingNCT06722586Phase 4
- A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06722235Phase 3
- Role of Acute Phase Proteins In Diagnosis of Immune ThrombocytopeniaRecruitingNCT06715215Not applicable
- Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITPRecruitingNCT06686927Phase 2
- Neonatal Platelet Transfusion Threshold TrialRecruitingNCT06676904Not applicable
- Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Destined to Undergo Elective Invasive SurgeryRecruitingNCT06673498Phase 2
- A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITPRecruitingNCT06658834Phase 2
- Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid LeukemiaRecruitingNCT06599762Phase 2
- Platelet Transfusion in Critically Ill Patients With ThrombocytopeniaNot yet recruitingNCT06599385Phase 3
- Prednisone Plus IVIg vs. Prednisone for ITP During PregnancyRecruitingNCT06577909Phase 2
- Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of ThrombocytopeniaRecruitingNCT06562738Phase 4
- Observatory of Immunological Thrombopenic Purpura in the Brest RegionRecruitingNCT06556888
- Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.RecruitingNCT06531018Phase 1/2
- Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of EpilepsyNot yet recruitingNCT06491303
- The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITPRecruitingNCT06479317Not applicable
- The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITPRecruitingNCT06479304Not applicable
- The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITPRecruitingNCT06479291Not applicable
- TPO-RA Treatment on Immune Tolerance Induction of ITP Patients With Sustained Platelet Recovery After Treatment TerminationRecruitingNCT06478537Phase 2
- Observational Study on the Outcome of Patients With ITP Who Underwent Splenectomy After 2010Not yet recruitingNCT06466824
- A Multicenter Randomized Controlled Study on the Treatment of Refractory CTIT With Romiplostim N01 Compared to Recombinant Human ThrombopoietinNot yet recruitingNCT06440824Phase 3
- Hetrombopag for the Thrombocytopenia Induced by Concurrent ChemoradiotherapyRecruitingNCT06433830Phase 2
- Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune DiseasesNot yet recruitingNCT06417398Early Phase 1
- A Multicentre Real-world Study of Heptapopal Ethanolamine Tablets in Concurrent/Sequential Radioimmunoinduced ThrombocytopeniaNot yet recruitingNCT06376435
- Impact of Acute ITTP Therapies on Long Term Neurologic and Cognitive Outcomes in ITTP SurvivorsNot yet recruitingNCT06358703
- Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune Thrombocytopenia (ITP)RecruitingNCT06352281Phase 1/2
- Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney InjuryRecruitingNCT06349577Not applicable
- An Clinical Study of CD19 CAR NK Cells for the Treatment of Refractory Primary Immune ThrombocytopeniaRecruitingNCT06337474Early Phase 1
- Avatrombopag in the Treatment of Pediatric Immune ThrombocytopeniaRecruitingNCT06281327Phase 2
- Explore the Relationship Between Platelet Count and Bleeding Score in ITPRecruitingNCT06273956
- UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid LeukemiaRecruitingNCT06245746Phase 1
- Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCTRecruitingNCT06202625Phase 2/3
- Romiplostim in Chemotherapy-Induced ThrombocytopeniaRecruitingNCT06201663Phase 3
- Teriflunomide for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT06190145Phase 2
- Performance Evaluation of the Biological Diagnosis of HITRecruitingNCT06180785
- The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune ThrombocytopeniaRecruitingNCT06176911Phase 2
- Risk Factors of Thrombocytopenia In Chronic Kidney Disease And Hemodialysis Patients In Assiut University HospitalsNot yet recruitingNCT06163144
- Thrombopoietin Agonists in Patients With Idiopathic Thrombocytopenic PurpuraNot yet recruitingNCT06137105
- Ketogenic Diet Improves Thrombocytopenia in Cancer PatientsNot yet recruitingNCT06106139Phase 1/2
- The Efficacy and Safety of Hetrombopag as Secondary Prevention to Chemotherapy-induced Thrombocytopenia in Patients With Gynecologic MalignanciesNot yet recruitingNCT06099925Phase 2
- Study Comparing Platelet Transfusion Volumes in Premature BabiesNot yet recruitingNCT06095648Not applicable
- A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)RecruitingNCT06094881Phase 2
- Immune Markers in Pediatric ITP on Second Line TherapyNot yet recruitingNCT06093529
- Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic PurpuraNot yet recruitingNCT06073925Early Phase 1
- Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.Not yet recruitingNCT06066762
- Antiplatelet Therapy for AIS Patients With ThrombocytopeniaRecruitingNCT06053021Not applicable
- The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer PatientsNot yet recruitingNCT06036966Phase 2
- Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced ThrombocytopeniaRecruitingNCT06033300Not applicable
- Anti-CD38 Antibody Treating Evans SyndromeRecruitingNCT06014775Phase 2
- A 6-month Follow-up Study of Patients With Severe Fever With Thrombocytopenia SyndromeRecruitingNCT06011902
- Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune ThrombocytopeniaRecruitingNCT06004856Phase 3
- Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAICRecruitingNCT06001567Phase 2
- Telitacicept for the Treatment of Connective Tissue Disease-associated ThrombocytopeniaRecruitingNCT05998759Phase 2
- A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Immune ThrombocytopeniaRecruitingNCT05995054Phase 2
- Anti-CD38 Antibody Treating APS With ThrombocytopeniaRecruitingNCT05983952Phase 2
- A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate ThrombocytopeniaRecruitingNCT05980806Phase 2
- Hetrombopag in Secondary Prevention of XPO-1 Inhibitor-induced Thrombocytopenia in LymphomaNot yet recruitingNCT05969158Phase 2
- Assessment of Risk Factors and Outcome of Thrombocytopenia in ICU PatientsNot yet recruitingNCT05958511